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Pseudomonas luteola is agram-negative bacillus rarely causing human 
infections. However, Reports have been building up on different types 
of infections caused by this potentially emerging microorganism. Here 
we report a case of liver mass with necrosis, sub-phrenic and pleural 
effusions. P. luteola liver infection was treated successfully as inpatient 
for few days with imipenem followed by ciprofloxacin. The bacterial 
isolate was found susceptible to a wide range of antimicrobial agents-
but was resistant to colistin.
Keywords: Pseudomonas luteola, liver mass, liver abscess, colistin.
Introduction
Pseudomonas luteola is a motile, aerobic, lactose non-fermenter gram-
negative bacillus and oxidase negative but catalse positive (formerly 
classified as CDC group Ve-1 and named Chryseomonas luteola) [ 1]. 
Also, P. luteola has been found frequently in natural water bodies, soil, 
and environments and is considered to be a saprophyte or commensal 
organism[1].It has been reported to cause different infections; including 
indwelling vascular catheter causing repeated bacteremia, sever peri-
tonitis in a patient requiring continuous peritonealdialysis, bile infec-
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tions in an obstructed jaundiced patient, meningitis 
in a newborn, prosthetic valve infective endocarditis 
implanted for a degenerative rheumatic valve dis-
ease in a 13-year-old boy, and aortic bioprosthesis 
infection in a 53 years old man 16 months follow-
ing its implantation, neonatal sepsis, skin abscess 
with bacteremia in a healthy adult patient and non-
traumatic septic arthritis in a nine years old boy[2-
10]. Furthermore, in an unusual presentation,in 16 
years old boy with autoimmune thrombocytopenia 
on steroids, P. luteola presented as a mediastinal 
mass mimicking a mediastinal malignant lymphoma 
and showing Splendore-Hoeppli phenomenon on 
cytological examination of the “mass”[11]. Here we 
present a unique case of P. luteola infection pre-
senting as a liver mass with necrosis, sub-phrenic 
and pleural effusion (Figure 1).
The case 
A 43 year old female patient, medically free, with 
history of surgeries for weight loss; gastric ring 
in 2007 which was removed in 2011 and sleeve 
gastrectomy was done in April, 2013 successfully 
without any post-operative complications, she lost 
23 kg. On January, 2014 the patient was admitted 
to Medical Center of Jordan Hospital,complaining 
of right sided upper abdominal pain radiating to 
the back, continuous, stabbing in nature, increases 
with movement. Pain started mild and increased in 
severity in the 4 days prior to admission, and was 
alleviated with paracetamol. She denied changes in 
bowel habit or stool color, there was no fever,chills, 
night sweats, nausea or vomiting and jaundice and 
had good appetite. Liver function tests were within 
Figure1.  Liver involvement as seen; (A) shows the diaphragm (white arrow) with pleural and sub-phrenic fluid on both sides. 
Axial view(B) and coronal views (B and D) showing a big mass/abscess (yellow arrows)
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normal limits except for albumin which was 3 gm/dl. 
White blood cells count was 20.7 X 103/mm3 (86% 
neutrophils) on admission (16/1/2014) and 10.8 X 
103/mm3 on discharge (26/1/2014) hemoglobin was 
10.2 gm/dl and MCV 86.0.A triple phase liver CT 
scan and ultrasound showed multiple ill-defined hy-
podense lesions mainly in segment 6 and 7 of liver 
with questionable abscess formation. A CT-guided 
liver biopsy was done for histopathological and 
microbiological studies. Liver histology revealed in-
flammatory lesion and tissue culture showed heavy 
growth of P. luteola.
On January 19th, 2014 the patient has developed 
spikes of fever, and her Chest X-Ray showed right 
sided pleural effusion and mild sub-phrenic abscess, 
which was drained under CT guidance. A tube left 
in place which was removed later, subphrenic and 
pleural fluids cultures were sterile. Antimicrobial 
susceptibility testing showed that P. luteola was 
susceptible to most antimicrobials tested, including 
carbapenems, β-lactams-β-lactamase inhibitors, 
aminoglycosides, quinolones, tetracycline, tigecy-
clin, ampicillin, aztreonam, cephalosporins and co-
trimoxazolebut Cefixime was intermediate suscepti-
ble and colistin was resistant as tested by Versa Trek 
automated system (1 Thermo Fisher Way Oakland 
Village, OH 44146. USA). 
The patient was started on imipenem-cilastatin 500 
mg every 6 hours for 6 days with effervescence 
of fever and abdominal symptoms, and thenshe 
was switched to oral ciprofloxacin 750 mg every 
12 hours, stayed on it for few daysas an inpatient 
with progressive improvement. Then, she was dis-
charged on same oral regimen. Two weeks after 
discharge she was evaluated as an outpatient, she 
was well with no complaints; follow up abdominal 
CT scan showed near complete resolution of the 
liver mass/necrosis and residual minimal amounts 
of fluids in the pleural space and sub-hepatic above 
right kidney. She was kept on oral ciprofloxacin for 
ten more days. Around seven weeks later she was 
phoned at home and was back in good condition.
Discussion
Although this patient was a “healthy” woman, 
buther albumin was lowon admission and lost 
weight secondary to her two weight-reducing sur-
geries, during which stomach ring was placed in the 
first surgery for four years. Our patient presented 
with a liver mass/abscess and sub-phrenic as wellas 
pleural effusion. Only the biopsied liver tissue grew 
P. luteola, mean while both the sub-phrenic and 
pleural fluids did not grow any microorganism in-
cluding P. luteola. The patient responded swiftly to 
imipenem therapy and later improvement was sus-
tained on oral ciprofloxacin, without the need for 
outpatient parenteral antimicrobial therapy (OPAT).
To our knowledge, we could not find on literature 
search a similar presentation i.e. liver mass/abscess 
with intra-abdominal and intra thoracic fluid effu-
sions. However, most of adult human infections oc-
curred in patients with indwelling devices, except 
in pediatric age group where it has been reported 
to occur without indwelling devices in a neonate 
where it caused sepsis syndrome, without an in-
dwelling device [12].
An interesting point to note is that the current 
P.luteola isolate was resistant to colistin, similar to 
Burkholderia cepacia complex [14]. P. luteola was 
reported from a clinical isolate to have a novel 
β-lactamase gene, blaLUT-1, that is chromosomal-
ly-encoded [1]. It was observed that this R-gene 
develop resistance to cephalosporins with variable 
susceptibility to penicillins. This β-lactam resistance 
phenotype suggests that this microbe may produce 
a natural β-lactamase; it may be used as a marker 
to differentiate strains especially in infection control 
[1]. Nevertheless, this microorganism may require to 
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be kept under surveillance for potential inclusion 
as emergent infectious pathogen in a nosocomial 
setting.
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